Global Payments Other Income (Expense) decreased by 43.7% to -$208.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 89.0%, from -$110.50M to -$208.85M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 12.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$75.10M | -$75.87M | -$84.46M | -$91.57M | -$96.23M | -$114.79M | -$113.23M | -$111.79M | -$163.48M | -$140.36M | -$118.32M | -$126.22M | -$114.01M | -$94.78M | -$116.05M | -$110.50M | -$116.73M | -$122.30M | -$145.36M | -$208.85M |
| QoQ Change | — | -1.0% | -11.3% | -8.4% | -5.1% | -19.3% | +1.4% | +1.3% | -46.2% | +14.1% | +15.7% | -6.7% | +9.7% | +16.9% | -22.4% | +4.8% | -5.6% | -4.8% | -18.8% | -43.7% |
| YoY Change | — | — | — | — | -28.1% | -51.3% | -34.1% | -22.1% | -69.9% | -22.3% | -4.5% | -12.9% | +30.3% | +32.5% | +1.9% | +12.5% | -2.4% | -29.0% | -25.3% | -89.0% |